Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Carol P. Y. Lau, Kwok Chuen Wong, Lin Huang, Gang Li, Stephen K.W. Tsui & Shekhar Madhukar Kumta. (2015) A mouse model of luciferase-transfected stromal cells of giant cell tumor of bone. Connective Tissue Research 56:6, pages 493-503.
Read now
Read now
Carol P. Y. Lau, Lin Huang, Kwok Chuen Wong & Shekhar Madhukar Kumta. (2013) Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. Connective Tissue Research 54:6, pages 439-449.
Read now
Read now
Articles from other publishers (50)
Diana Nogueira, Inês Morais Caldas & Ricardo Jorge Dinis-Oliveira. (2023) Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects. Archives of Oral Biology 155, pages 105792.
Crossref
Crossref
Junho Jung, Jae‐In Ryu, Gyu‐Jo Shim & Yong‐Dae Kwon. (2023) Effect of agents affecting bone homeostasis on short‐ and long‐term implant failure. Clinical Oral Implants Research 34:S26, pages 143-168.
Crossref
Crossref
Chenhang Yu, Xinyang Hu, Qingang Hu, Yongbin Mou & Liang Ding. (2023) Teriparatide-induced alleviation of medication-related osteonecrosis of the jaw: Potential molecular mechanisms. Medical Hypotheses, pages 111161.
Crossref
Crossref
Bridget Boston, Deepak Ipe, Bogdan Capitanescu, Andrei Gresita, Stephen Hamlet, Robert Love, Michael Hadjiargyrou, Chien‐Ling Huang, Iulian Nusem, Rodica Ileana Miroiu, Aurel Popa‐Wagner, Patrick Hans‐Heinrich Warnke & Eugen Bogdan Petcu. (2023) Medication‐related osteonecrosis of the jaw: A disease of significant importance for older patients. Journal of the American Geriatrics Society 71:8, pages 2640-2652.
Crossref
Crossref
Anna Nasulewicz‑Goldeman, Waldemar Goldeman, Diana Papiernik, Marcin Nowak, Ewa Mrówczyńska & Joanna Wietrzyk. (2023) Anti‑metastatic activity of aromatic aminomethylidenebisphosphonates in a mouse model of 4T1 cell‑derived breast cancer. Oncology Reports 50:1.
Crossref
Crossref
Heng Qiu, Christopher Hosking, Emel Rothzerg, Ariela Samantha, Kai Chen, Vincent Kuek, Haiming Jin, Sipin Zhu, Alice Vrielink, Kevin Lim, Michael Foley & Jiake Xu. (2023) ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption. Journal of Biological Chemistry 299:2, pages 102889.
Crossref
Crossref
Athanasios D Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya A Khan, M Carola Zillikens & Jean-Jacques Body. (2022) Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS. The Journal of Clinical Endocrinology & Metabolism 107:5, pages 1441-1460.
Crossref
Crossref
Minu Anoop, Aswathy R. Nambiar, Shantikumar V. Nair, Manzoor Koyakutty & Anusha Ashokan. (2022) Zoledronic acid conjugated calcium phosphate nanoparticles for applications in cancer immunotherapy. Materials Today Communications 30, pages 103065.
Crossref
Crossref
Federica Bellone, Antonino Catalano, Angelo Ruggero Sottile, Agostino Gaudio, Saverio Loddo, Francesco Corica & Nunziata Morabito. (2021) Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D. Frontiers in Medicine 8.
Crossref
Crossref
Akanksha Srivastava, Graciela M. Nogueras Gonzalez, Yimin Geng, Alexander M. Won, Jeffrey Myers, Yisheng Li & Mark S. Chambers. (2021) Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis. Journal of Immunotherapy and Precision Oncology 4:4, pages 196-207.
Crossref
Crossref
D. Hadaya, A. Soundia, I. Gkouveris, O. Bezouglaia, S.M. Dry, F.Q. Pirih, T.L. Aghaloo & S. Tetradis. (2021) Antiresorptive-Type and Discontinuation-Timing Affect ONJ Burden. Journal of Dental Research 100:7, pages 746-753.
Crossref
Crossref
Yuka Kameda, Mamoru Aizawa, Taira Sato & Michiyo Honda. (2021) Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment. International Journal of Molecular Sciences 22:4, pages 1889.
Crossref
Crossref
Yumi Kambara, Eizaburo Kobayashi, Hiroaki Katsuragi & Akira Tanaka. (2021) Effects of Zoledronic Acid on Human Gingival Fibroblasts and Human Umbilical Vein Endothelial Cells. Journal of Hard Tissue Biology 30:2, pages 123-130.
Crossref
Crossref
Lina He, Xiangyu Sun, Zhijie Liu, Yanfen Qiu & Yumei Niu. (2020) Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. International Journal of Oral Science 12:1.
Crossref
Crossref
Zhifei Su, Jiehang Li, Xuan Bai, Franklin R. Tay, Min Zhang, Kunneng Liang, Libang He, He Yuan & Jiyao Li. (2020) Borate bioactive glass prevents zoledronate‐induced osteonecrosis of the jaw by restoring osteogenesis and angiogenesis. Oral Diseases 26:8, pages 1706-1717.
Crossref
Crossref
Stefanie de Groot, Hanno Pijl, Ayoub Charehbili, Saskia van de Ven, Vincent T. H. B. M. Smit, Elma Meershoek-Klein Kranenbarg, Joan B. Heijns, Laurence J. C. van Warmerdam, Lonneke W. Kessels, M. Wouter Dercksen, Manon J. A. E. Pepels, Hanneke W. M. van Laarhoven, Birgit E. P. J. Vriens, Hein Putter, Marta Fiocco, Gerrit-Jan Liefers, Jacobus J. M. van der Hoeven, Johan W. R. Nortier & Judith R. Kroep. (2019) Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01). Breast Cancer Research 21:1.
Crossref
Crossref
Russell Hughes, Xinyue Chen, Keith D. Hunter, Jamie K. Hobbs, Ingunn Holen & Nicola J. Brown. (2019) Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid. The FASEB Journal 33:11, pages 12768-12779.
Crossref
Crossref
J. Chang, A. E. Hakam & L. K. McCauley. (2018) Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw. Current Osteoporosis Reports 16:5, pages 584-595.
Crossref
Crossref
Junho Jung, Jung Soo Park, Leonardo Righesso, Andreas Max Pabst, Bilal Al-Nawas, Yong-Dae Kwon & Christian Walter. (2018) Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro. Clinical Oral Investigations 22:7, pages 2527-2534.
Crossref
Crossref
Byunghee Yoo, Bryan C. Fuchs & Zdravka Medarova. (2018) New Directions in the Study and Treatment of Metastatic Cancer. Frontiers in Oncology 8.
Crossref
Crossref
Caterina Musolino, Giacomo Oteri, Alessandro Allegra, Manuela Mania, Angela D’Ascola, Angela Avenoso, Vanessa Innao, Andrea Gaetano Allegra & Salvatore Campo. (2018) Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. Annals of Hematology 97:7, pages 1259-1269.
Crossref
Crossref
Beom�Su Kim, Sun‑Sik� Yang, Cheol‑Sang� Kim & Jun� Lee. (2018) Zoledronate suppresses VEGF‑induced capillary tube formation and inhibits expression of interferon‑induced transmembrane protein‑1 in human umbilical vein endothelial cells. International Journal of Molecular Medicine.
Crossref
Crossref
Paulo Goberlânio de Barros Silva, Antonio Ernando Carlos Ferreira Junior, Camila Carvalho de Oliveira, Luiz André Cavalcante Brizeno, Deysi Viviana Tenazoa Wong, Roberto César Pereira Lima Júnior, Fabrício Bitú Sousa, Mário Rogério Lima Mota & Ana Paula Negreiros Nunes Alves. (2017) Chronic treatment with zoledronic acid increases inflammatory markers in periodontium of rats. Journal of Oral Pathology & Medicine.
Crossref
Crossref
Si-yong Gao, Guang-sen Zheng, Lin Wang, Yu-jie Liang, Si-en Zhang, Xiao-mei Lao, Kan Li & Gui-qing Liao. (2017) Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB. PLOS ONE 12:6, pages e0179248.
Crossref
Crossref
Hiroshi Takeyama, Tsutomu Sakiyama, Tomoko Wakasa, Kotaro Kitani, Keisuke Inoue, Hiroaki Kato, Shinya Ueda, Masanori Tsujie, Yoshinori Fujiwara, Masao Yukawa, Yoshio Ohta & Masatoshi Inoue. (2017) Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literature. Oncology Letters 13:6, pages 4290-4294.
Crossref
Crossref
Marco Fioramonti, Daniele Santini, Michele Iuliani, Giulia Ribelli, Paolo Manca, Nicola Papapietro, Filippo Spiezia, Bruno Vincenzi, Vincenzo Denaro, Antonio Russo, Giuseppe Tonini & Francesco Pantano. (2017) Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. Oncotarget 8:12, pages 20113-20121.
Crossref
Crossref
P. G. de Barros Silva, M. E. Q. L. Verde, L. A. C. Brizeno, D. V. T. Wong, R. C. P. Lima Júnior, F. B. Sousa, M. R. L. Mota & A. P. N. N. Alves. (2016) Immune cell profile of dental pulp tissue treated with zoledronic acid. International Endodontic Journal.
Crossref
Crossref
Pablo H. Cutini, Mar?a B. Rauschemberger, Marisa J. Sandoval & Virginia L. Massheimer. (2016) Vascular action of bisphosphonates: In vitro effect of alendronate on the regulation of cellular events involved in vessel pathogenesis. Journal of Molecular and Cellular Cardiology 100, pages 83-92.
Crossref
Crossref
PG de Barros Silva, CC de Oliveira, LAC Brizeno, DVT Wong, RCP Lima Júnior, RP Gonçalves, FB Sousa, MRL Mota, R de Albuquerque Ribeiro & APNN Alves. (2016) Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw. Oral Diseases 22:7, pages 649-657.
Crossref
Crossref
Hiroshi Makino, Shin Nishio, Hiroshi Tsubamoto, Muneaki Shimada, Ryutaro Nishikawa, Kentaro Kai, Kimihiko Ito, Tomoko Mizuno, Kimio Ushijima & Ken‐ichiro Morishige. (2016) Treatment and prognosis of bone metastasis from cervical cancer (KCOG‐G1202s). Journal of Obstetrics and Gynaecology Research 42:6, pages 701-706.
Crossref
Crossref
Jia Liu, Eric Hau, Matthew Links & Peter H Graham. (2016) Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation. Asia-Pacific Journal of Clinical Oncology 12:2, pages e352-e355.
Crossref
Crossref
Daniele Fanale, Valeria Amodeo, Viviana Bazan, Lavinia Insalaco, Lorena Incorvaia, Nadia Barraco, Marta Castiglia, Sergio Rizzo, Daniele Santini, Antonio Giordano, Sergio Castorina & Antonio Russo. (2016) Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?. Oncotarget 7:20, pages 29321-29332.
Crossref
Crossref
Christoph Klingelh?ffer, Manja Klingelh?ffer, Steffen M?ller, Tobias Ettl & Ulrich Wahlmann. (2016) Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?. Dentomaxillofacial Radiology 45:5, pages 20160065.
Crossref
Crossref
F. Tzermpos, A. Ismail, M. Pavli & K.I. Tosios. (2015) Osteonecrosis of the mandible in a patient with lung adenocarcinoma undergoing anti‐angiogenic therapy with bevacizumab. Oral Surgery 9:1, pages 40-46.
Crossref
Crossref
Mohammed Qaisi, Jamie Hargett, Matthew Loeb, Jeffrey Brown & Ronald Caloss. (2016) Denosumab Related Osteonecrosis of the Jaw with Spontaneous Necrosis of the Soft Palate: Report of a Life Threatening Case. Case Reports in Dentistry 2016, pages 1-6.
Crossref
Crossref
Naomi Gronich & Gad Rennert. 2016. Trends in Breast Cancer Prevention. Trends in Breast Cancer Prevention
183
212
.
John E. Fantasia. (2015) The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw. Oral and Maxillofacial Surgery Clinics of North America 27:4, pages 547-553.
Crossref
Crossref
James L. Borke, Bennett McAllister, Tiffenie Harris, Maryke Neiberg, Chestine Guevarra-Toth, Sadanand Fulzele, Charles Stoianovici & Carlos Guerra. (2015) Correlation of changes in the mandible and retina/choroid vasculature of a rat model of BRONJ. Journal of Cranio-Maxillofacial Surgery 43:7, pages 1144-1150.
Crossref
Crossref
Paulo Goberlânio de Barros Silva, Antonio Ernando Carlos Ferreira Junior, Carolina Rodrigues Teófilo, Maritza Cavalcante Barbosa, Roberto César Pereira Lima Júnior, Fabrício Bitú Sousa, Mário Rogério Lima Mota, Ronaldo de Albuquerque Ribeiro & Ana Paula Negreiros Nunes Alves. (2015) Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis. Archives of Oral Biology 60:9, pages 1237-1245.
Crossref
Crossref
Jing Y. Krzeszinski & Yihong Wan. (2015) New therapeutic targets for cancer bone metastasis. Trends in Pharmacological Sciences 36:6, pages 360-373.
Crossref
Crossref
Vianey Gonzalez-Villasana, Enrique Fuentes-Mattei, Cristina Ivan, Heather J. Dalton, Cristian Rodriguez-Aguayo, Ricardo J. Fernandez-de Thomas, Burcu Aslan, Paloma del C. Monroig, Guermarie Velazquez-Torres, Rebecca A. Previs, Sunila Pradeep, Nermin Kahraman, Huamin Wang, Pinar Kanlikilicer, Bulent Ozpolat, George Calin, Anil K. Sood & Gabriel Lopez-Berestein. (2015) Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer. Clinical Cancer Research 21:9, pages 2127-2137.
Crossref
Crossref
Shou-Sheng Liu, Xiao-Pai Wang, Xiu-Bo Li, Jia-Yi Liang, Ling-Ling Liu, Ying Lu, Xue-Yun Zhong & Yun-Xian Chen. (2014) Zoledronic acid exerts antitumor effects in NB4 acute promyelocytic leukemia cells by inducing apoptosis and S phase arrest. Biomedicine & Pharmacotherapy 68:8, pages 1031-1036.
Crossref
Crossref
Antonietta Rizzo, Gabriella Misso, Nazario Bevilacqua, Giovanna Donnarumma, Angela Lombardi, Massimiliano Galdiero & Michele Caraglia. (2014) Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. International Immunopharmacology 22:1, pages 66-72.
Crossref
Crossref
Tetsuro Ohba, Justin M.M. Cates, Heather A. Cole, David A. Slosky, Hirotaka Haro, Jiro Ichikawa, Takashi Ando, Herbert S. Schwartz & Jonathan G. Schoenecker. (2014) Pleiotropic effects of bisphosphonates on osteosarcoma. Bone 63, pages 110-120.
Crossref
Crossref
Michael Gnant. (2014) Role of bisphosphonates in postmenopausal women with breast cancer. Cancer Treatment Reviews 40:3, pages 476-484.
Crossref
Crossref
Jamal Zekri, Maged Mansour & Syed Mustafa Karim. (2014) The anti-tumour effects of zoledronic acid. Journal of Bone Oncology 3:1, pages 25-35.
Crossref
Crossref
Carlos M. Galmarini, Olivier Tredan & Felipe C. Galmarini. (2013) Concomitant resistance and early-breast cancer: should we change treatment strategies?. Cancer and Metastasis Reviews 33:1, pages 271-283.
Crossref
Crossref
Simon P. Gampenrieder, Gabriel Rinnerthaler & Richard Greil. (2014) Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?. Breast Care 9:5, pages 323-330.
Crossref
Crossref
David A. Gerard, Eric R. Carlson, Jack E. Gotcher & David O. Pickett. (2014) Early Inhibitory Effects of Zoledronic Acid in Tooth Extraction Sockets in Dogs Are Negated by Recombinant Human Bone Morphogenetic Protein. Journal of Oral and Maxillofacial Surgery 72:1, pages 61-66.
Crossref
Crossref
Giuseppe De Rosa, Gabriella Misso, Giuseppina Salzano & Michele Caraglia. (2013) Bisphosphonates and Cancer: What Opportunities from Nanotechnology?. Journal of Drug Delivery 2013, pages 1-17.
Crossref
Crossref